ID minimum # Dx & Tx, based on transactions
The major study objectives were to:
- Increase confidence in updated market size projections for the client to share internally and externally.
- Develop a valuable baseline database against which periodic future comparisons could detect important changes in key physician practice and treatment patterns.
- Anchor our estimates on a commercial ICD claims database after we determined how to fill in gaps and correct errors and other problems with claims data.
Fill in gaps in transaction- based estimates
Update projections as appropriate
Case 1: Current Treatments and Best Opportunities
for a forthcoming first-in-class treatment
Case 2: Move from Pre-Launch to Blockbuster
in a crowded market
Case 3: Competitive Landscape of Usage Tracking
plus demand-forecasting updates & support
of a drug for a target condition
for treating cancer; a 5-nation comparison
Click links below to learn how we met other clients' business needs:
Epidemiologic studies:
- A health needs assessment of Coachella Valley, California
- Market sizing for conditions treated by several orphan drugs
Delphi method consensus building:
Our collaborative estimating and forecasting methodology
combines independent analysis with maximum use of feedback for building consensus among world-recognized experts who interact anonymously.
- Estimating annual prevalence of diseases when secondardy data are lacking
Econometric modeling:
- Optimal sales force sizing
- Valuing certain market assets in a potential company buyout
- Determining whether a client should buy a generic manufacturer, and at what price
- Development of a desktop system for marketing staff to determine relative contributions of sales force vs. contract effects
- Relative financial contributions of client's sales force vs. that of a contractor marketing the client's drug
- Forecast of likely company sales by product line
Focus groups/ATU studies:
We have enhanced quantitative studies with qualitative services such as:
- Branding, messaging, buyer preference focus groups
- Pre-launch qualitative research for a new atypical antipsychotic and continued tracking/market strategy evaluation studies
© 2014-2022 Clarity Pharma Research® LLC | All Rights Reserved | Privacy Policy
To learn more about our services, contact information@claritypharma.com.
Subscribe to our newsletter at: http://eepurl.com/ovQcb
We’d Like to Discuss Product-Optimizing Case Studies Like This One:
Resizing a Market